ClinicalTrials.gg
Not yet recruitingNCT07907835Updated Oct 30, 2026

Comparative Effects Of Exercises Targeting Upper Trapezius In Patients With Non Specific Neck Pain

An interventional study of Myokinetic stretching and Integrated neuromuscular inhibition technique in Non Specific Neck Pain, sponsored by University of Management and Technology Lahore. Not yet recruiting at 1 site in Pakistan. Open to participants aged 20 Years to 40 Years. Per ClinicalTrials.gov, last updated 2026-10-30.

Sponsored by University of Management and Technology Lahore · Not applicable, Interventional, and Treatment

Updated Oct 30, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
34
Allocation
Randomized
Ages
20 Years to 40 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 205 studies in Neck Pain with a site in Pakistan — 52 open to participants now, 60 under way, none of them phase 3. Neck Pain · Pakistan.

Planned enrollment
137th of 195
34 · median 42
Started
2026
with 35 others
No phase
195 of 205
52 open now
Primary completion
2026-12
later than 46 of 59 live
Registered
199th of 205
by date
Lead sponsor
7 of 205
University of Management and Technology Lahore

Among the 205 studies in Neck Pain with a site in Pakistan, this one is the 137th largest by planned enrollment of the 195 interventional ones, is one of 36 that started in 2026, is one of 195 with no phase, reaches primary completion later than 46 of the 59 other live ones, and was the 199th registered.

By phase

205 studies; the count open now beside each. This study's row is marked.

No phasethis study195 · 52 open
Observational10 · 0 open

By the year they started

First in 2017; this study’s year is marked. 36 started in 2026.

Size and results

Median enrollment 42 across the 195 interventional studies, 128 across the 10 observational. Of the 131 that completed or were terminated, 0 (0%) have results posted.

Was this useful?
Watch this landscapeDownload CSVWith an account: a weekly mail of what changed among 205 studies in Neck Pain with a site in Pakistan, or all of them as a file.
02

Study summary

Group A includes Myokinetic stretching, it is a form of myofascial release technique in which the taut band is released by incorporating active or passive stretching with movement until the intended release from the tight band is accomplished.

Group B includes Integrated neuromuscular inhibition technique, It combines three interventions: Muscle Energy Technique, Strain Counter-Strain, and Ischemic Compression.

03

Conditions studied

  • Non Specific Neck Pain

Browse trials for

Keywords

  • Myokinetic stretching
  • Integrated Neuromuscular Inhibition Technique
  • Upper trapezius
  • Non specific neck pain
04

Who can participate

Ages eligible
20 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Non-specific neck pain ≥ 20-40years old
  • Tight band or trigger points in upper trapezius
  • Both genders.
  • Neck pain from more than months.
  • NPRS scores 4-6

Exclusion criteria

Exclusion Criteria:

  • or infection.
  • History of trauma or fracture to cervical spine
  • Vascular syndromes like basilar insufficiency.
  • Pain radiating to upper extremities or cervical radiculopathy, disc herniation.
  • Inflammatory arthropathies.
  • Degenerative changes of cervical spine (cervical spondylosis) , spinal stenosis, or other diagnosed spinal pathologies.
  • Cervical spine surgery
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
34 participants (estimated)

Study arms

  • Experimental
    Myokinetic stretching

    Group A includes Myokinetic stretching, it is a form of myofascial release technique in which the taut band is released by incorporating active or passive stretching with movement until the intended release from the tight band is accomplished.

    Other: Myokinetic stretching

  • Active comparator
    Integrated neuromuscular inhibition technique

    Group B includes Integrated neuromuscular inhibition technique, It combines three interventions: Muscle Energy Technique, Strain Counter-Strain, and Ischemic Compression

    Other: Integrated neuromuscular inhibition technique

Interventions

  • OtherMyokinetic stretching

    Group A includes Myokinetic stretching, it is a form of myofascial release technique in which the taut band is released by incorporating active or passive stretching with movement until the intended release from the tight band is accomplished.

  • OtherIntegrated neuromuscular inhibition technique

    Group B includes Integrated neuromuscular inhibition technique, It combines three interventions: Muscle Energy Technique, Strain Counter-Strain, and Ischemic Compression.

06

What researchers measure

Primary outcomes

  1. • NPRS

    11-point numeric scale with 0 representing No pain, 1-3 representing Mild Pain (nagging, annoying, interfering little with ADLs), 4-6 representing Moderate Pains (interferes significantly with ADLs), 7-10 representing Sever Pain (disabling, unable to perform.

    Time frame: Baseline and after 4 weeks

  2. Neck Disability Index

    It has total 10 domains Each domain is scored on a scale from 0 to 5, with higher scores indicating greater disability. The total score ranges from 0 to 50 and can also be expressed as a percentage of disability. Scores are generally interpreted as follows: 0-4 indicates no disability, 5-14 mild disability, 15-24 moderate disability, 25-34 severe disability, and 35 or higher complete disability.

    Time frame: Baseline and after 4 weeks

  3. SMARTPHONE INCLINOMETER

    Cervical range of motion (ROM) will be assessed using a smartphone inclinometer/clinometer application installed on a smartphone. The same smartphone device and application will be used throughout the study to maintain consistency of measurements.

    Time frame: Baseline and after 4 weeks

07

Study locations

1 site
  • UMT
    Lahore, Punjab Province 54000, Pakistan
08

References and documents

Related links

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2026; primary completion for Dec 2026, 2 months later.

Of 763 non-industry interventional studies with no phase under Neck Pain, half reached primary completion within 7 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 15. This study's planned 2 months is below that.

Counting every sponsor, half of 772 studies reached it within 7 months; a quarter within 3 and three quarters within 15.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 25, 2026
First posted
Oct 30, 2026
StartEst.
Oct 25, 2026
Primary completionEst.
Dec 31, 2026
CompletionEst.
Dec 31, 2026
Last update
Oct 30, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 30, 2026
Show all 1 update
  1. Oct 30, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07907835
Lead sponsor
University of Management and Technology Lahore
Responsible party
Sponsor
First posted
Oct 30, 2026
Start date
Oct 25, 2026 (estimated)
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Oct 30, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion